公开(公告)号：EP1671645A4

公开(公告)日：2007-07-25

申请号：EP04772922

申请日：2004-09-03

申请人： CHUGAI PHARMACEUTICAL CO LTD ,  PERSEUS PROTEOMICS INC ,  ABURATANI HIROYUKI

发明人： ABURATANI HIROYUKI ,  FUKAYAMA MASASHI ,  YAMAUCHI NAOKO ,  SUZUKI MASAMI ,  KATO ATSUHIKO ,  TSUCHIYA MASAYUKI

IPC分类号： A61K39/395 ,  A61P35/00 ,  C07K16/18 ,  C07K16/30 ,  G01N33/543 ,  G01N33/574

CPC分类号： G01N33/57446 ,  A61K2039/505 ,  C07K16/303 ,  G01N33/57438

摘要： A bile duct cancer cell proliferation inhibitor containing antiglypican 3 antibody as the active ingredient. It is preferable that the antiglypican 3 antibody has a cytotoxic activity such as antibody-dependent cellular cytotoxicity (ADCC) activity or complement-dependent cytotoxicity (CDC) activity. A diagnostic for bile duct cancer containing antiglypican 3 antibody.